|
1. |
Serum and Peritoneal Fluid Amylase Levels in CAPD |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 169-172
Ralph J. Caruana,
John Burkart,
Denise Segraves,
Sheila Smallwood,
Jean Haymore,
Betty Disher,
Preview
|
PDF (658KB)
|
|
摘要:
The mean serum amylase of 42 asymptomatic CAPD patients was elevated but was not significantly different from that of a group of chronic hemodialysis patients. Serum amylase levels in CAPD patients with peritonitis were not elevated with respect to asymptomatic patients. Amylase activity was not detectable in the peritoneal fluid of 38/42 asymptomatic patients and 6/13 peritonitis patients and was present at low levels in the other 11 patients. Patients with other abdominal conditions (pancreatitis, cholecystitis and small bowel perforation) had very marked elevations of serum and/or peritoneal fluid amylase which differentiated them from the asymptomatic and peritonitis patients. Although hyperamylasemia is common in asymptomatic CAPD patients and in those with peritonitis, measurement of serum and peritoneal fluid amylase levels is useful in the evaluation of CAPD patients presenting with abdominal symptoms.
ISSN:0250-8095
DOI:10.1159/000167458
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
2. |
Eosinophilia in the Diagnosis of Atheroembolic Renal Disease |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 173-177
Balakuntalam S. Kasinath,
Howard L. Corwin,
Anil K. Bidani,
Stephen M. Korbet,
Melvin M. Schwartz,
Edmund J. Lewis,
Preview
|
PDF (977KB)
|
|
摘要:
We report 6 patients with eosinophilia and atheroembolic renal disease. Histologic examination of biopsy of kidney or skin revealed extensive atheroemboli in the vasculature. However, no evidence of vascular or tubulointerstitial inflammation was observed. Eosinophil count ranged from 540 to 2,000 cells/mm3. Upon review of the literature, 80% (29 out of 36) of patients with adequately reported total and differential leukocyte counts had eosinophilia in association with atheroembolic disease. In contrast, review of the clinical records of 40 consecutive patients with acute renal failure seen during an 18-month period uncovered only 1 case of eosinohilia (2.5%). This latter patient was established as having acute interstitial nephritis. Thus eosinophilia appears to be a helpful diagnostic clue to the presence of atheroembolic renal disease
ISSN:0250-8095
DOI:10.1159/000167459
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
3. |
An Increase in Circulating IgA Antibodies to Gliadin in IgA Mesangial Glomerulonephritis |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 178-183
Jérôme Laurent,
Anne Branellec,
Jean-Marie Heslan,
Guy Rostoker,
Charles Bruneau,
Chantal André,
Liliane Intrator,
Gilbert Lagrue,
Preview
|
PDF (1127KB)
|
|
摘要:
In IgA glomerulonephritis (GN), the pathogenic role of IgA is well documented, but the specificity of these IgA is unknown. Cases of celiac disease associated with IgA GN have been reported and led us to investigate the role of gliadin sensitivity. We measured IgA, IgG and IgM antibodies to gliadin, β-lactoglobulin and ovalbumin by ELISA (results expressed as optical density; OD) in 27 patients with primary IgA GN, 14 with membranous GN (MGN), 21 with idiopathic nephrotic syndrome (INS) and 21 healthy controls. The normal value for antigliadin IgA was less than 0.650 OD. 19/27 patients with IgA GN had a raised level versus 2/14 in MGN and 2/21 INS (p < 0.001: IgA GN vs. MGN, INS and controls). Antibodies to β-lactoglobulin were rarely found and were not more frequent in IgA GN. Cross-reactivity with reticulin was investigated in 16 patients who were serum-positive for IgA antigliadin: no reticulin antibodies were detected by immunofluorescence. Antigliadin IgA are of diagnostic value for distinguishing IgA GN from other GN, with a sensitivity of 70%, a specificity of 89%, a positive predictive value of 83% and a negative one of 79
ISSN:0250-8095
DOI:10.1159/000167460
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
4. |
Low-Output Left Ventricular Failure in End-Stage Renal Disease |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 184-191
Patrick S. Parfrey,
John D. Harnett,
Sheila Griffiths,
Henry Gault,
Paul E. Barre,
Ronald D. Guttmann,
Preview
|
PDF (1700KB)
|
|
摘要:
To determine the factors associated with low-output left ventricular failure (LVF) in endstage renal disease (ESRD), we performed echocardiography and gated cardiac scan on 217 nondiabetic dialysis and transplant patients. The prevalence of low-output LVF (ejection fraction < 55% and left ventricular end diastolic diameter s≥ 5.5 cm) in dialysis patients was 18% and in transplant patients 2%. The 26 patients with LVF were compared to 52 controls without LVF, matched by age, sex and year of starting treatment for ESRD, but not for current ESRD therapy. Mean age was 55 ± (SEM) 14 years; 73% of the patients in both groups were males. Duration of treatment for ESRD was 5.6 ± 4.3 years in patients, compared to 5.1 ± 4.1 years in controls. Significant differences between LVF patients and controls included current treatment (73% of cases were on hemodialysis and 8% were transplanted, compared to 48 and 42%; χ2 = 9.9, p < 0.01), high serum creatinine, smoking and high serum alkaline phosphatase. There were no differences for current blood pressure, proportion on treatment for hypertension, left ventricular wall thickness, symptomatic ischemic heart disease, proportion with functioning vascular access, degree of weight gain between dialyses, hemoglobin level or high transfusion requirement. Multiple logistic regression demonstrated the most significant and independent variables associated with LVF were high alkaline phosphatase (suggestive of hyperparathyroidism), smoking and high serum creatinine levels (reflecting degree of uremia). Dialysis patients with LVF (n = 23) were compared to dialysis patients who had normal echocardiograms (n = 29). Using multiple logistic regression, the 3 most important variables associated with LVF were age, high serum alkaline phosphatase and smoking. We conclude that the most important factors associated with LVF in ESRD include age, hyperparathyroidism, smoking and degree of u
ISSN:0250-8095
DOI:10.1159/000167461
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
5. |
Diagnosis of Hypothyroidism in Patients with End-Stage Renal Disease |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 192-197
Winson W. Tang,
Elaine M. Kaptein,
Shaul G. Massry,
Preview
|
PDF (1216KB)
|
|
摘要:
Hypothyroidism may occur more commonly in patients with end-stage renal disease (ESRD) than in the general population. The signs and symptoms of both hypothyroidism and uremia may be similar. To evaluate the usefulness of clinical and routine laboratory findings in the diagnosis of hypothyroidism in patients with ESRD, we compared 6 patients with documented primary hypothyroidism who had serum thyrotrophin (TSH) levels above 20 μU/ml with 12 euthyroid patients. The euthyroid patients were divided into two groups. The first was matched with the hypothyroid patients for age, renal disease and duration of dialysis, while the second group was matched for serum total thyroxine and free T4 index values. Serum TSH levels were normal ( < 10 μU/ml) in both of these latter groups. There were no significant differences in the clinical manifestations among the three groups of patients, except for hoarseness of voice which was significantly more common in the hypothyroid uremic patients (p = 0.03). No significant differences were noted on electrocardiogram, physical examination, chest x-ray or echocardiography. Routine laboratory values were not different. Therapy of the uremic hypothyroid patients with L-thyroxine was associated with improvement or resolution of many of the symptoms and signs of hypothyroidism that otherwise would have been attributed to the uremic state. Our results indicate that the diagnosis of hypothyroidism in uremic patients cannot be made by clinical or routine laboratory values and rests on the presence of an overtly elevated serum TSH concentration. Thus, routine measurement of serum TSH levels may be warranted in all patients with ESRD who have reduced total T4 or free T4 index values to insure accurate diagnosis and allow institution of specific therap
ISSN:0250-8095
DOI:10.1159/000167462
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
6. |
Diclofenac, a Nonsteroidal Anti-Inflammatory Drug, Decreases Proteinuria in Some Glomerular Diseases: A Controlled Study |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 198-202
Jérôme Laurent,
Dominique Belghiti,
Charles Bruneau,
Gilbert Lagrue,
Preview
|
PDF (744KB)
|
|
摘要:
Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) was first used in glomerulonephritis (GN) in 1966 but its efficiency is still debated. We studied the antiproteinuric effect of such a treatment in a double-blind study. 29 GN patients with normal renal function (17 membranoproliferative GN, 12 IgA GN) were randomly assigned to receive 100 mg/day of diclofenac or placebo for at least 2 months. There was a significant antiproteinuric effect of diclofenac versus placebo with a fall of 70% in the diclofenac group versus 6 % in the placebo group (p < 0.001 with the Mann-Whitney test). The median was 3 mg/min at onset and 2.45 mg/min after 2 months treatment with the placebo. In the diclofenac group, it was 2.2 and 0.95 mg/min, respectively (p < 0.01). Diclofenac did not significantly increase creatinine levels. Gastric irritation was noted only once. This study establishes the short-term antiproteinuric ation of diclofenac. Whether this action affets the final outcome is not yet determined.
ISSN:0250-8095
DOI:10.1159/000167463
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
7. |
Noninvasive Diagnosis of Uremic Osteodystrophy: Uses and Limitations |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 203-211
James G. Heaf,
Preben Joffe,
Jan Pødenphant,
Jan R. Andersen,
Preview
|
PDF (1601KB)
|
|
摘要:
45 bone biopsies from patients with chronic uremia were reviewed to define which noninvasive investigations were of value in predicting the histological diagnosis and to quantify the spectrum of uremic bone disease at a center that has consistently used an aluminum-free dialysis bath. 17 biopsies were taken postmortem. 15 patients received conservative treatment, the rest were on maintenance dialysis. 13 patients had symptomatic bone disease. Virtually all patients with a uremia duration greater than 3 years had uremic osteodystrophy. All patients with clinical bone disease, hypercalcemia or raised alkaline phosphatase activity had osteodystrophy, but the specific histology was not indicated. Greatly raised parathyroid levels suggested secondary hyperparathyroidism, but the test was only 100% specific when 20 times normal. Total aluminum consumption was highly indicative of bone aluminum concentration (p < 0.0001) and aluminum-related osteomalacia (5 cases), suggesting that a considerable proportion of uremic bone disease is iatrogenic. Serum aluminum was of some use in the diagnosis of aluminum-related osteomalacia, but was not wholly reliable. Bone mineral content (BMC) using both forearm measurements and total body bone mineral levels (TBBM) were assessed in 32 patients and were found to be reduced in 12, with a preponderance of secondary hyperparathyroidism. BMC and TBBM were negatively correlated to resorbing surfaces and bone formation rate, suggesting that secondary hyperparathyroidism is the uremic bone disease that represents the greatest threat to bone mass. It is concluded that while noninvasive investigations give considerable information, reliable diagnosis requires the use of histological methods.
ISSN:0250-8095
DOI:10.1159/000167465
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
8. |
Eicosanoids of Platelets and Vascular Wall in Chronic Renal Insufficiency |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 212-220
Helmut Sinzinger,
Christian Leithner,
Preview
|
PDF (1691KB)
|
|
摘要:
There is good evidence that retention products accumulating in chronic renal insufficiency influence prostaglandin (PG) synthesis, thus affecting platelet-vascular wall interaction. The vascular PGI2 synthesis is increased and prolonged in vitro, the plasma factor activity enhanced. A defective platelet function is frequently observed; it is completely restored by peritoneal dialysis, but only partially by hemodialysis. The sensitivity of platelets to PGI2 and its plasmatic degradation are unchanged. There is evidence of a shift of arachidonic acid metabolism from cyclooxygenase to lipoxygenase. These changes may be attributed to undialyzable plasma constituents, the ‘middle molecules
ISSN:0250-8095
DOI:10.1159/000167466
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
9. |
Polycythaemia following Renal Transplantation: An Association with Azathioprine Dosage? |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 221-225
David Brynley Webb,
Kathleen Anne Price,
Richard David Hutton,
Robert Gordon Newcombe,
John Redcliffe Salaman,
Jennifer Orchard,
Preview
|
PDF (941KB)
|
|
摘要:
Patients from a renal transplantation unit with an unusually high incidence of polycythaemia were divided into polycythaemic and control groups. The rate of rise of haemoglobin concentration was not significantly different in the two groups. The polycythaemic group received a significantly lower dose of azathioprine (p < 0.005) and included more patients with polycystic disease than the control group (p < 0.05). An effect of azathioprine on bone marrow function was suggested by the polycythaemic group also having a higher mean white cell count (p < 0.02). Azathioprine dosage correlated negatively with post-transplantation polycythaemia regardless of the original cause of renal failure.
ISSN:0250-8095
DOI:10.1159/000167467
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
10. |
Medical Art |
|
American Journal of Nephrology,
Volume 7,
Issue 3,
1987,
Page 226-226
Peter Andrews,
Preview
|
PDF (100KB)
|
|
ISSN:0250-8095
DOI:10.1159/000167468
出版商:S. Karger AG
年代:1987
数据来源: Karger
|
|